RESUMEN
Resumen En el presente artículo se realizó un análisis diagnóstico con miras a identificar acciones para favorecer la consolidación de una cadena productiva forestal en Arauca, Colombia, como estrategia de desarrollo. A partir de una investigación de tipo cualitativo, con consulta a expertos y con una metodología de planeación participativa, se desarrolló un análisis de debilidades, fortalezas, oportunidades y amenazas (DOFA). También se identificaron elementos que dieron soporte para un posterior análisis Mactor® (Matriz de alianzas y conflictos, tácticas, objetivos y recomendaciones) para identificar intereses de los actores de la cadena, y finalmente se propuso un modelo de representación de la cadena productiva forestal del departamento, con sus respectivos eslabones y agentes.
Abstract In the present article, a diagnostic analysis aimed at identifying actions to favor the consolidation of a forest productive chain in Arauca, Colombia, as a development strategy, was carried out. From a qualitative investigation, with consultation to experts and with a methodology of participative planning, an analysis of weaknesses, strengths, opportunities and threats was developed (SWOT). Elements also were identified, to gave support for a subsequent Mactor® analysis (Matrix of alliances and conflicts, tactics, objectives and recommendations) in order to identify interests of the actors in the chain, and finally was proposed a model of representation of the forest productive chain of the department, with its respective links and agents.
Resumo No presente artigo, foi realizada uma análise diagnóstica que objetivou identificar ações para favorecer a consolidação de uma cadeia produtiva florestal em Arauca, Colômbia, como estratégia de desenvolvimento. A partir de uma investigação do tipo qualitativa, com consulta a especialistas e com uma metodologia de planejamento participativo, foi desenvolvida uma análise de Forças, Fraquezas, Oportunidades e Ameaças (SWOT). Elementos que deram suporte para uma análise Mactor® subsequente (Matriz de alianças e conflitos, táticas, objetivos e recomendações) para identificar os interesses dos atores da cadeia também foram identificados e, finalmente, um modelo de representação da cadeia de produção florestal da departamento, com seus respectivos links e agentes.
RESUMEN
OBJECTIVE:To know the current situation of pharmaceutical industry in China and provide suggestion for its fur-ther development. MATHODS:The structure-conduct-performance model in industrial organization theory was adopted to analyze the pharmaceutical industry statistics data in China from 2004 to 2012. RESULTS&CONCLUSIONS:The characteristic of pharma-ceutical industry market structure was numerous pharmaceutical industries,but with low industry concentration;market entry barri-ers were low;the degree of product differentiation was increasing;new product output rate was basically increased year by year in recent years. The characteristic of pharmaceutical industry market conduct was weak pricing power,more than 2 400 drugs’pricing were monitored by government;the advertisement input of drugs was increased,and only 2013 ads served through the network plat-form was reached 630 million yuan;pharmaceutical industry mergers and acquisitions were active,and there were 43 public phar-maceutical industry mergers and acquisitions in 2013;R & D spending was annually increased,and the numbers of patent applica-tions and invention patents in force in 2012 were respectively 9 580 and 10 073. The characteristic of market performance was in-crease of sales profit rate year by year,reaching 11% in 2012;the output rate of new products for several years growth rate was reached 16.68% in 2011. However,there are still large gap between China and foreign pharmaceutical industry. It is suggested that the industry structure of development of pharmaceutical industry in China should be improved by strategic merger;increase R & D input;focus on building innovative research and development platform,improve collaborative innovation capability;strengthen monitoring of pharmaceutical industry,and implement standardized management.
RESUMEN
To analyze the relationship between hospital non-price competition behavior and market structure, analyze the relationship between hospital market construction and health care costs gtowth. Methods:Using cross-province data(SCP) theory to establish the regression function of health cost expenditure, hospital market concentration ratio and the occupancy of public hospital market, process the empirical analysis based on the two-factor effectiveness model of panel data. Results: There is no medical arms race in hospital business under the current market concentration. Conclusion: The reinforcement of market competition played a more important role in the improvement of operational efficiency rather than the differences in the nature of property rights and the profit of hospitals.
RESUMEN
Objective To analyze the medical service market structure and the competitive status and in Suining county to make recommendations in accordance with the existing problems . Methods Data of annual business income,number of bed and health personnel in 14 hospitals of the third class and above were collected to do market concentration analysis and Herfindahl-Hirschman index(HHI)analy-sis. Results Market concentration degrees of three indicators were above 60.0%and the HHI score were all above 1700,which demonstrated that hospitals in Suining county was highly concentrated and the market structure of oligopoly was high. Conclusions Medical service market competition environment in Suining county is bad,therefore,it is necessary to introduce competition mechanism,optimize resource allocation,carry out open information thus to improve the service level of the township hospitals.
RESUMEN
OBJECTIVE:To provide references and suggestions for the further development of pharmaceutical industry in Hangzhou city.METHODS:Using the classic normal form of SCP in the industry economics,i.e.market structure-the manufacturer behavior-market performance,a transverse and longitudinal comparative study was carried out on the market structure,the manufacturer behavior and the market performance of the Hangzhou's pharmaceutical industry between 2003 and 2006.RESULTS:Hangzhou's pharmaceutical industry was characterized by oligarch model in concentration degree,low differentiation in products;high barrier of entry and exit;low strength in advertisement,and rational in the merge and recombination.The manufacturers in this area attached increasingly importance to technological progress and the market performance was remarkable.CONCLUSIONS:Considering the status quo of Hangzhou's pharmaceutical industry,it is advisable for the manufacturers enlarge and strengthen their business,enhance its R&D investment and product differentiation,and stick to the market-oriented marketing concept.
RESUMEN
OBJECTIVE: To ascertain the main influencing factors of market performance of pharmaceutical industry in China for governmental reference in formulating pharmaceutical industry-related policies. METHODS: The influencing factors of market performance of pharmaceutical industry in China were optimized using multiple linear regression. RESULTS & CONCLUSIONS: The major influencing factors were proved to be the following: the minimum economical scale,current industrial concentration and production expansion capability,which are a little bit different from the classical market performance theory in which the three influencing factors are industrial market concentration,economical scale,and product differentiation.
RESUMEN
OBJECTIVE:To discuss the way to raise the market concentration ratio of pharmaceutical industry in China. METHODS:The present situations of market concentration ratios home and abroad were analysed and compared.RESULTS&CONCLUSION:The market concentration ratio of pharmaceutical industry was lower in China than that in foreign coun?tries.In order to raise the market concentration ratio of pharmaceutical industry in China,we should heighten the standard of market access,acquire,merge and procure existing pharmaceutical enterprises and lower the barrier to withdraw from market.
RESUMEN
Objective To assess the efficiency of central urban and rural hospitals in the 7 cities, counties and districts under the jurisdiction of Hangzhou City and the status of the medical markets so as to provide theoretical basis for the promotion of decentralized medical markets. Methods On the basis of defining the scope of a medical market, the HHI values of the medical markets in places where 37 hospitals in Hangzhou were located was calculated, the average efficiency of the various hospitals was measured by means of DEA, and an analysis was made on the correlation between the average efficiency and the HHI values. Results The central urban and rural medical markets in the various places surveyed, whose HHI values were all greater than 1 800, belonged to markets of monopolistic competition. Of the 37 hospitals, there were 11 whose relative efficiency reached 100% and another 11 whose relative efficiency was less than 60%. The greater the monopoly of a medical market, the lower the average efficiency of its hospitals. Conclusion Establishing competitive markets with low market concentration is an effective way of enhancing overall hospital efficiency.
RESUMEN
OBJECTIVE:To probe into the countermeasures to solve the obstacle of the Chinese artemisinin manufacture. METHODS:Market structure theory was applied to analyze the obstacle the Chinese artemisinin manufactures were facing and its reason. Then countermeasures and suggestions were provided. RESULTS&CONCLUSION:Chinese artemisinin manufactures can solve the obstacle by these measures,such as integration of the upper reaches of artemisinin recourses,establishment of artemisinin manufacture association,enhancement of research and development.